These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8085379)

  • 21. Enhancement of protective immune responses to Venezuelan equine encephalitis (VEE) virus with microencapsulated vaccine.
    Greenway TE; Eldridge JH; Ludwig G; Staas JK; Smith JF; Gilley RM; Michalek SM
    Vaccine; 1995; 13(15):1411-20. PubMed ID: 8578818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of protective immune responses against Venezuelan equine encephalitis (VEE) virus aerosol challenge with microencapsulated VEE virus vaccine.
    Greenway TE; Eldridge JH; Ludwig G; Staas JK; Smith JF; Gilley RM; Michalek SM
    Vaccine; 1998 Aug; 16(13):1314-23. PubMed ID: 9682396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved mucosal protection against Venezuelan equine encephalitis virus is induced by the molecularly defined, live-attenuated V3526 vaccine candidate.
    Hart MK; Caswell-Stephan K; Bakken R; Tammariello R; Pratt W; Davis N; Johnston RE; Smith J; Steele K
    Vaccine; 2000 Jul; 18(26):3067-75. PubMed ID: 10825611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mucosal immunity induced by parenteral immunization with a live attenuated Venezuelan equine encephalitis virus vaccine candidate.
    Charles PC; Brown KW; Davis NL; Hart MK; Johnston RE
    Virology; 1997 Feb; 228(2):153-60. PubMed ID: 9123821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunity to airborne challenge with Venezuelan equine encephalitis virus develops rapidly after immunization with the attenuated vaccine strain TC-83.
    Phillpotts RJ
    Vaccine; 1999 May; 17(19):2429-35. PubMed ID: 10392625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The immunogenic properties of a recombinant vaccinia virus with an incorporated DNA copy of the 26S RNA of the Venezuelan equine encephalomyelitis virus].
    Sviatchenko VA; Agapov EV; Urmanov IKh; Serpinskiĭ OI; Frolov IV; Kolykhalov AA; Ryzhikov AB; Netesov SV
    Vopr Virusol; 1993; 38(5):222-6. PubMed ID: 8284922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetics of cytokine expression and regulation of host protection following infection with molecularly cloned Venezuelan equine encephalitis virus.
    Grieder FB; Davis BK; Zhou XD; Chen SJ; Finkelman FD; Gause WC
    Virology; 1997 Jul; 233(2):302-12. PubMed ID: 9217054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutralizing antibody responses of humans and mice to vaccination with Venezuelan encephalitis (TC-83) virus.
    Fillis CA; Calisher CH
    J Clin Microbiol; 1979 Oct; 10(4):544-9. PubMed ID: 93607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attenuation of Venezuelan equine encephalitis virus strain TC-83 is encoded by the 5'-noncoding region and the E2 envelope glycoprotein.
    Kinney RM; Chang GJ; Tsuchiya KR; Sneider JM; Roehrig JT; Woodward TM; Trent DW
    J Virol; 1993 Mar; 67(3):1269-77. PubMed ID: 7679745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study of homologous and heterologous antibody response in California horses vaccinated with attenuated Venezuelan equine encephalomyelitis vaccine (strain TC-83).
    Ferguson JA; Reeves WC; Milby MM; Hardy JL
    Am J Vet Res; 1978 Mar; 39(3):371-6. PubMed ID: 637386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A viral vaccine vector that expresses foreign genes in lymph nodes and protects against mucosal challenge.
    Davis NL; Brown KW; Johnston RE
    J Virol; 1996 Jun; 70(6):3781-7. PubMed ID: 8648713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant vaccinia/Venezuelan equine encephalitis (VEE) virus expresses VEE structural proteins.
    Kinney RM; Esposito JJ; Johnson BJ; Roehrig JT; Mathews JH; Barrett AD; Trent DW
    J Gen Virol; 1988 Dec; 69 ( Pt 12)():3005-13. PubMed ID: 2462013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Melatonin treatment enhances the efficiency of mice immunization with Venezuelan equine encephalomyelitis virus TC-83.
    Negrette B; Bonilla E; Valero N; Pons H; Garcia Tamayo J; Chacín-Bonilla L; Medina-Leendertz S; Añez F
    Neurochem Res; 2001 Jul; 26(7):767-70. PubMed ID: 11565607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of telemetry to assess vaccine-induced protection against parenteral and aerosol infections of Venezuelan equine encephalitis virus in non-human primates.
    Pratt WD; Gibbs P; Pitt ML; Schmaljohn AL
    Vaccine; 1998; 16(9-10):1056-64. PubMed ID: 9682359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of the two major envelope proteins of equine arteritis virus as a heterodimer is necessary for induction of neutralizing antibodies in mice immunized with recombinant Venezuelan equine encephalitis virus replicon particles.
    Balasuriya UB; Heidner HW; Hedges JF; Williams JC; Davis NL; Johnston RE; MacLachlan NJ
    J Virol; 2000 Nov; 74(22):10623-30. PubMed ID: 11044106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In mice the efficiency of immunization with Venezuelan Equine Encephalomyelitis virus TC-83 is transiently increased by dehydroepiandrosterone.
    Negrette B; Bonilla E; Valero N; Giraldoth D; Medina-Leendertz S; Añez F
    Invest Clin; 2001 Dec; 42(4):235-40. PubMed ID: 11787268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An alphavirus replicon particle chimera derived from venezuelan equine encephalitis and sindbis viruses is a potent gene-based vaccine delivery vector.
    Perri S; Greer CE; Thudium K; Doe B; Legg H; Liu H; Romero RE; Tang Z; Bin Q; Dubensky TW; Vajdy M; Otten GR; Polo JM
    J Virol; 2003 Oct; 77(19):10394-403. PubMed ID: 12970424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetically engineered, live, attenuated vaccines protect nonhuman primates against aerosol challenge with a virulent IE strain of Venezuelan equine encephalitis virus.
    Reed DS; Lind CM; Lackemeyer MG; Sullivan LJ; Pratt WD; Parker MD
    Vaccine; 2005 May; 23(24):3139-47. PubMed ID: 15837213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Live vaccinia-rabies virus recombinants, but not an inactivated rabies virus cell culture vaccine, protect B-lymphocyte-deficient A/WySnJ mice against rabies: considerations of recombinant defective poxviruses for rabies immunization of immunocompromised individuals.
    Lodmell DL; Esposito JJ; Ewalt LC
    Vaccine; 2004 Sep; 22(25-26):3329-33. PubMed ID: 15308356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Features of cross protection between Sindbis and Venezuelan equine encephalitis viruses in mice--relationship of route of immunization to protection.
    Fine DL; Allen WP; Wilkins LB
    J Gen Virol; 1974 Sep; 24(3):401-8. PubMed ID: 4427105
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.